Furoscix (furosemide subcutaneous 80 mg/10 mL cartridge kit) — Blue Cross Blue Shield of New Mexico

Initial criteria

• The requested agent will be approved when ONE of the following is met: 1. For BCBS NM Fully Insured or NM HIM members, ALL of the following: A. The patient does NOT have any FDA labeled contraindications to the requested agent AND B. The requested indication is a rare disease AND C. ONE of the following: 1. The patient has another FDA labeled indication for the requested agent and route of administration OR 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR 2. ALL of the following: A. The member resides in Ohio AND B. The plan is Fully Insured or HIM Shop (SG) AND C. The patient does NOT have any FDA labeled contraindications to the requested agent AND D. ONE of the following: 1. The patient has another FDA labeled indication for the requested agent and route of administration OR 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR 3. The prescriber has submitted TWO articles from major peer-reviewed professional medical journals (e.g., JAMA, NEJM, Lancet) supporting the proposed use(s) as generally safe and effective; case studies are not acceptable.

Reauthorization criteria

• Reauthorization will follow the same clinical criteria as initial approval; length of approval 12 months.

Approval duration

12 months